Spots Global Cancer Trial Database for newly diagnosed secondary or high risk aml
Every month we try and update this database with for newly diagnosed secondary or high risk aml cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia | NCT04230239 | Newly Diagnosed... | CPX-351 | 60 Years - 75 Years | PETHEMA Foundation | |
Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia | NCT04230239 | Newly Diagnosed... | CPX-351 | 60 Years - 75 Years | PETHEMA Foundation | |
Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia | NCT04230239 | Newly Diagnosed... | CPX-351 | 60 Years - 75 Years | PETHEMA Foundation |